93 related articles for article (PubMed ID: 10083340)
1. Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system.
Bilbao G; Zhang H; Contreras JL; Zhou T; Feng M; Saito I; Mountz JD; Curiel DT
Transplant Proc; 1999; 31(1-2):792-3. PubMed ID: 10083340
[No Abstract] [Full Text] [Related]
2. On/off switching Fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system.
Fujino M; Li XK; Okuyama T; Funeshima N; Tamura A; Enosawa S; Kita Y; Amano T; Yamada M; Amemiya H; Suzuki S
Transplant Proc; 1999; 31(1-2):753-4. PubMed ID: 10083322
[No Abstract] [Full Text] [Related]
3. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system.
Okuyama T; Fujino M; Li XK; Funeshima N; Kosuga M; Saito I; Suzuki S; Yamada M
Gene Ther; 1998 Aug; 5(8):1047-53. PubMed ID: 10326027
[TBL] [Abstract][Full Text] [Related]
4. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.
Zhang HG; Bilbao G; Zhou T; Contreras JL; Gómez-Navarro J; Feng M; Saito I; Mountz JD; Curiel DT
J Virol; 1998 Mar; 72(3):2483-90. PubMed ID: 9499110
[TBL] [Abstract][Full Text] [Related]
5. Controlled Fas ligand gene expression by Cre/loxP-mediated switching system: high levels of FasL expression result in lethal hepatitis.
Fujino M; Okuyama T; Li XK; Funeshima N; Tamura A; Enosawa S; Amano T; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2695-6. PubMed ID: 10578253
[No Abstract] [Full Text] [Related]
6. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
7. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F; Niwa H; Miyazaki J
Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
[TBL] [Abstract][Full Text] [Related]
8. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors.
Ng P; Parks RJ; Cummings DT; Evelegh CM; Sankar U; Graham FL
Hum Gene Ther; 1999 Nov; 10(16):2667-72. PubMed ID: 10566894
[TBL] [Abstract][Full Text] [Related]
9. Yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors.
Ng P; Cummings DT; Evelegh CM; Graham FL
Biotechniques; 2000 Sep; 29(3):524-6, 528. PubMed ID: 10997266
[TBL] [Abstract][Full Text] [Related]
10. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.
Aoki K; Barker C; Danthinne X; Imperiale MJ; Nabel GJ
Mol Med; 1999 Apr; 5(4):224-31. PubMed ID: 10448644
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of recombination by Cre transient expression in embryonic stem cells: comparison of various promoters.
Araki K; Imaizumi T; Okuyama K; Oike Y; Yamamura K
J Biochem; 1997 Nov; 122(5):977-82. PubMed ID: 9443813
[TBL] [Abstract][Full Text] [Related]
12. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Wang Y; Krushel LA; Edelman GM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3932-6. PubMed ID: 8632992
[TBL] [Abstract][Full Text] [Related]
13. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.
Kondo S; Okuda A; Sato H; Tachikawa N; Terashima M; Kanegae Y; Saito I
Nucleic Acids Res; 2003 Jul; 31(14):e76. PubMed ID: 12853653
[TBL] [Abstract][Full Text] [Related]
15. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo gene transfer to transplanted heart grafts using adenoviral vector.
Gojo S; Kitamura S; Niwaya K; Yoshida Y; Sakaguchi H; Kawachi K
Transplant Proc; 1996 Jun; 28(3):1818-9. PubMed ID: 8658897
[No Abstract] [Full Text] [Related]
17. Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system.
Habu Y; Miyano-Kurosaki N; Nagawa T; Matsumoto N; Takeuchi H; Takaku H
Antivir Chem Chemother; 2002 Sep; 13(5):273-81. PubMed ID: 12630675
[TBL] [Abstract][Full Text] [Related]
18. Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells.
Baba Y; Nakano M; Yamada Y; Saito I; Kanegae Y
Microbiol Immunol; 2005; 49(6):559-70. PubMed ID: 15965304
[TBL] [Abstract][Full Text] [Related]
19. Cre-LoxP-regulated expression of monoclonal antibodies driven by an ovalbumin promoter in primary oviduct cells.
Oishi I; Kim S; Yoshii K; Esteban CR; Izpisua Belmonte JC
BMC Biotechnol; 2011 Jan; 11():5. PubMed ID: 21235743
[TBL] [Abstract][Full Text] [Related]
20. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells.
Zhang HG; Liu D; Heike Y; Yang P; Wang Z; Wang X; Curiel DT; Zhou T; Mountz JD
Nat Biotechnol; 1998 Nov; 16(11):1045-9. PubMed ID: 9831033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
